We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current DGX market cap is 16.88B. The company's latest EPS is USD 7.6513 and P/E is 19.77.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.3B | 2.29B | 2.37B | 2.4B | 2.49B |
| Operating Income | 347M | 245M | 300M | 355M | 330M |
| Net Income | 225M | 192M | 194M | 229M | 226M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.82B | 9.44B | 10.79B | 9.88B | 9.25B |
| Operating Income | 1.23B | 1.97B | 2.38B | 1.43B | 1.26B |
| Net Income | 858M | 1.43B | 2B | 946M | 854M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.48B | 14.02B | 13.95B | 13.88B | 16.1B |
| Total Liabilities | 6.94B | 7.6B | 7.41B | 7.15B | 9.17B |
| Total Equity | 6.46B | 6.34B | 6.47B | 6.66B | 6.84B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.84B | 14.03B | 13.61B | 12.84B | 14.02B |
| Total Liabilities | 7.08B | 7.14B | 7.05B | 6.83B | 7.6B |
| Total Equity | 5.69B | 6.81B | 6.48B | 5.93B | 6.34B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 745M | 1.27B | 154M | 514M | 870M |
| Investing | -947M | -1.06B | -213M | -413M | -2.05B |
| Financing | 30M | 160M | -153M | -516M | 1.25B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.24B | 2.01B | 2.23B | 1.72B | 1.27B |
| Investing | -411M | -772M | 21M | -543M | -1.06B |
| Financing | 225M | -1.27B | -2.54B | -1.73B | 160M |
| Market Cap | 16.88B |
| Price to Earnings Ratio | 19.77 |
| Price to Sales Ratio | 1.82 |
| Price to Cash Ratio | 24.61 |
| Price to Book Ratio | 2.63 |
| Dividend Yield | 1.98% |
| Shares Outstanding | 111.62M |
| Average Volume (1 week) | 913.6k |
| Average Volume (1 Month) | 821.9k |
| 52 Week Change | 11.17% |
| 52 Week High | 165.32 |
| 52 Week Low | 123.04 |
| Spread (Intraday) | 3 (1.95%) |
| Company Name | Quest Diagnostics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.questdiagnostics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
